Published in Blood on September 01, 2010
Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels. BMC Med Genet (2011) 1.02
A common polymorphism in the LDL receptor gene has multiple effects on LDL receptor function. Hum Mol Genet (2013) 0.96
BRG1 variant rs1122608 on chromosome 19p13.2 confers protection against stroke and regulates expression of pre-mRNA-splicing factor SFRS3. Hum Genet (2013) 0.86
Meta-analysis of low density lipoprotein receptor (LDLR) rs2228671 polymorphism and coronary heart disease. Biomed Res Int (2014) 0.84
Low levels of serum paraoxonase activities are characteristic of metabolic syndrome and may influence the metabolic-syndrome-related risk of coronary artery disease. Exp Diabetes Res (2011) 0.80
Mapping the binding region on the low density lipoprotein receptor for blood coagulation factor VIII. J Biol Chem (2013) 0.79
Genomic Study of Cardiovascular Continuum Comorbidity. Acta Naturae (2015) 0.78
Genetic risk factors for spontaneous intracerebral haemorrhage. Nat Rev Neurol (2015) 0.77
Association of -77T>C and Arg194trp polymorphisms of XRCC1 with risk of coronary artery diseases in Iranian population. Iran J Basic Med Sci (2016) 0.76
Familial hypercholesterolemia: Molecular characterization of possible cases from the Azores Islands (Portugal). Meta Gene (2014) 0.75
Increased coagulation factor VIII activity in patients with familial hypercholesterolemia. Blood (2011) 0.75
LDL receptor polymorphisms revisited. Blood (2010) 0.75
Identification of the Functional Variant(s) that Explain the Low-Density Lipoprotein Receptor (LDLR) GWAS SNP rs6511720 Association with Lower LDL-C and Risk of CHD. PLoS One (2016) 0.75
Transcriptional similarity in couples reveals the impact of shared environment and lifestyle on gene regulation through modified cytosines. PeerJ (2016) 0.75
LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers. PLoS One (2016) 0.75
Common genetic variants do not associate with CAD in familial hypercholesterolemia. Eur J Hum Genet (2013) 0.75
Sex-specific association of SH2B3 and SMARCA4 polymorphisms with coronary artery disease susceptibility. Oncotarget (2017) 0.75
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet (2009) 6.83
Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med (2014) 5.47
Immunoassay for human serum hepcidin. Blood (2008) 5.32
Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med (2009) 4.48
A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A (2002) 4.22
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet (2002) 4.19
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med (2016) 3.88
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
Characterization of transcriptional complexity during berry development in Vitis vinifera using RNA-Seq. Plant Physiol (2010) 2.46
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr (2004) 2.45
FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr (2008) 2.42
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. J Am Coll Cardiol (2011) 2.39
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17
Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome. Lancet (2002) 2.15
Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One (2008) 2.13
N-terminal pro-BNP in sclerodermic patients on bosentan therapy for PAH. Rheumatol Int (2007) 2.03
SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids (2008) 2.02
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet (2006) 1.90
Association between four SNPs on chromosome 9p21 and myocardial infarction is replicated in an Italian population. J Hum Genet (2007) 1.87
Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel. Arterioscler Thromb Vasc Biol (2006) 1.84
Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. Am J Hum Genet (2003) 1.81
Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet (2010) 1.79
Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood (2007) 1.78
IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am J Hum Genet (2007) 1.77
Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early-onset myocardial infarction. J Am Coll Cardiol (2011) 1.73
Biochemical and genetic markers of iron status and the risk of coronary artery disease: an angiography-based study. Clin Chem (2002) 1.69
Factor VII Deficiency. Semin Thromb Hemost (2009) 1.69
Risks factors for highly unstable response to oral anticoagulation: a case-control study. Br J Haematol (2005) 1.67
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin. Blood (2009) 1.66
Differential regulation of iron homeostasis during human macrophage polarized activation. Eur J Immunol (2010) 1.64
Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet (2003) 1.64
Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study. Rheumatol Int (2010) 1.59
On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease. Eur J Hum Genet (2006) 1.54
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica (2009) 1.51
Haplotype block structure study of the CFTR gene. Most variants are associated with the M470 allele in several European populations. Eur J Hum Genet (2006) 1.51
Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol (2009) 1.48
An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction. Am J Hum Genet (2007) 1.48
Prevalence of body iron excess in the metabolic syndrome. Diabetes Care (2005) 1.48
Aldosterone to Renin ratio in a primary care setting: the Bussolengo study. J Clin Endocrinol Metab (2004) 1.47
Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus. J Clin Periodontol (2008) 1.43
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res (2003) 1.41
TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals. Blood (2011) 1.39
An unusual heart failure: cardiac amyloidosis due to light-chain myeloma. Circulation (2011) 1.39
Immunoglobulin-resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patient. Transfusion (2013) 1.39
Human parvovirus B19 infection and autoimmunity. Autoimmun Rev (2008) 1.38
ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood (2002) 1.37
Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost (2005) 1.35
In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med (2006) 1.34